Kwality Pharmaceuticals share news and announcements
NSE: KPLBSE: 539997Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹3,618.30.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹3,661 Cr1,235th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 10 Aug 2026
- 45.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 19 May 2026
- 11.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 10 Aug 2026
- 27.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 10 Aug 2026
- 25.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 19 May 2026
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 38,71643.8% delivered
Kwality Pharmaceuticals share news and announcements
373 announcements, routine notices left out, newest first. Page 5 of 8.
Jun 2022
10 Jun · Migration Of Equity Shares Of Company From SME Platform Of BSE Limited To Main Board Of BSE Limited
3 Jun · Intimation Of In-Principle Approval For Migration Of Company From BSE SME Platform To BSE Main Board.
May 2022
31 May · Reply To The Query Of BSE For Submission Of Revised Consolidated Balance Sheet For The Half Year Ended On September 30, 2018 As Per SEBI Format
31 May · Reply To The Query Of BSE For Submission Of Revised Consolidated Balance Sheet For F.Y. Ended On 31-03-2018 As Per SEBI Format
25 May · Reply To The Query Of BSE For Submission Of Revised Standalone Balance Sheet For The Half Year Ended On September 30, 2018 As Per SEBI Format
25 May · Reply To The Query Of BSE For Submission Of Revised Standalone Balance Sheet For F.Y. Ended On 31-03-2018 As Per SEBI Format
18 May · Board meeting
Meeting on 28 May 2022: half yearly results and audited results
Apr 2022
20 Apr · Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended On March 31, 2022
12 Apr · Compliance Certificate For The Year Ended On 31St March, 2022
11 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Feb 2022
Jan 2022
17 Jan · Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 08 Jan · Shareholding for the Period Ended December 31, 2021
Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click ....
Dec 2021
Nov 2021
2 Nov · Board meeting
Meeting on 10 Nov 2021
Oct 2021
16 Oct · Shareholding for the Period Ended September 30, 2021
Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click ....14 Oct · Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 012 Oct · Board meeting
Meeting on 22 Oct 2021: half yearly results
Sep 2021
7 Sep · Reg. 34 (1) Annual Report
Aug 2021
Jul 2021
16 Jul · Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2021
23 Jun · Board meeting
Meeting on 30 Jun 2021: audited results and half yearly results
Apr 2021
21 Apr · Shareholding for the Period Ended March 31, 2021
Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click ....18 Apr · Compliance Certificate Pursuant To Regulation 7 (3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended On 31St March,2021,
17 Apr · Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended On March 31, 2021